<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lieder HR</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Universitätsklinikum Essen</funding><funding>European COST Action in Cardioprotection</funding><pagination>865-876</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10517043</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(5)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>The role of platelets during myocardial ischemia/reperfusion (I/R) is ambivalent. They contribute to injury but also to cardioprotection. Repeated blood flow restriction and reperfusion in a tissue/organ remote from the heart (remote ischemic conditioning, RIC) reduce myocardial I/R injury and attenuate platelet activation. Whether or not platelets mediate RIC's cardioprotective signal is currently unclear.&lt;h4>Methods and results&lt;/h4>Venous blood from healthy volunteers (without or with pretreatment of 500/1000 mg aspirin or 180 mg ticagrelor orally, 2-3 h before the study, n = 18 each) was collected before and after RIC (3 × 5 min blood pressure cuff inflation at 200 mmHg on the left upper arm/5 min deflation). Washed platelets were isolated. Platelet-poor plasma was used </pubmed_abstract><journal>Cardiovascular drugs and therapy</journal><pubmed_title>Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor.</pubmed_title><pmcid>PMC10517043</pmcid><funding_grant_id>CA16225</funding_grant_id><funding_grant_id>SFB 1116 B8</funding_grant_id><pubmed_authors>Kleinbongard P</pubmed_authors><pubmed_authors>Heusch G</pubmed_authors><pubmed_authors>Schror K</pubmed_authors><pubmed_authors>Lieder HR</pubmed_authors><pubmed_authors>Tsoumani M</pubmed_authors><pubmed_authors>Andreadou I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor.</name><description>&lt;h4>Purpose&lt;/h4>The role of platelets during myocardial ischemia/reperfusion (I/R) is ambivalent. They contribute to injury but also to cardioprotection. Repeated blood flow restriction and reperfusion in a tissue/organ remote from the heart (remote ischemic conditioning, RIC) reduce myocardial I/R injury and attenuate platelet activation. Whether or not platelets mediate RIC's cardioprotective signal is currently unclear.&lt;h4>Methods and results&lt;/h4>Venous blood from healthy volunteers (without or with pretreatment of 500/1000 mg aspirin or 180 mg ticagrelor orally, 2-3 h before the study, n = 18 each) was collected before and after RIC (3 × 5 min blood pressure cuff inflation at 200 mmHg on the left upper arm/5 min deflation). Washed platelets were isolated. Platelet-poor plasma was used </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2025-04-26T23:28:57.171Z</modification><creation>2025-04-06T17:31:42.893Z</creation></dates><accession>S-EPMC10517043</accession><cross_references><pubmed>35595877</pubmed><doi>10.1007/s10557-022-07345-9</doi></cross_references></HashMap>